Dermatomyositis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
Condition:   Juvenile Dermatomyositis Interventions:   Drug: Baricitinib;   Biological: pharmacokinetics study;   Biological: dosage of cytokines;   Biological: transcriptomic analysis;   Behavioral: Parent version of the Child Health Questionnaire (CHQ);   Behavioral: Childhood Health Assessment Questionnaire;   Biological: Pregnancy  test Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2022 Category: Research Source Type: clinical trials